Aggressive fibromatosis in children and adolescents: The italian experience

Cancer

Volumn 116, Issue 1, 2010, Pages 233-240

  Meazza, Cristina ^a   Bisogno, Gianni ^b   Gronchi, Alessandro ^a   Fiore, Marco ^a   Cecchetto, Giovanni ^b   Alaggio, Rita ^b   Milano, Giuseppe M ^c   Casanova, Michela ^a   Carli, Modesto ^b   Ferrari, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Aggressive fibromitosis; Desmoid tumor; Low dose chemotherapy; Methotrexate plus vinblastine vinorelbine; Prognostic factors; Surgery

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DICLOFENAC; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; NAVELBINE; RECOMBINANT ALPHA INTERFERON; SULINDAC; TAMOXIFEN; VINBLASTINE; VINCRISTINE;

ABDOMINAL DISEASE; ABDOMINAL FIBROMATOSIS; ABDOMINAL SURGERY; ADOLESCENT; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CONTROLLED STUDY; DESMOID TUMOR; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; EVENT FREE SURVIVAL; FEMALE; FIBROMATOSIS; FIBROSIS; FRACTURE; GARDNER SYNDROME; GROWTH RETARDATION; HUMAN; INFANT; LOW DRUG DOSE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MINIMAL RESIDUAL DISEASE; OVERALL SURVIVAL; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD; SURGICAL TECHNIQUE; SYSTEMIC THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; INFANT; MALE; METHOTREXATE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE; VINBLASTINE;

EID: 74549211241     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24679     Document Type: Article

References (32)

1. Goldblum J, Fletcher JA. Desmoid-type fibromatosis. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon, France: International Agency for Research on Cancer Press; 2002: 83-84.
2. Reitamo JJ, Scheinin TM, Hayry P. The desmoid syndrome: new aspects in the cause, pathogenesis and treatment of the desmoids tumor. Am J Surg. 1996;151:230-237.
3. Posner MC, Shiu MH, Newsome JL, et al. The desmoid tumor. Not a benign disease. Arch Surg. 1989;124:191-196.
4. Bertario L, Russo A, Sala P, et al. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol. 2003;21:1698-1707.
5. Gronchi A, Casali PG, Mariani L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol. 2003;21:1390-1397.
6. Dormans JP, Spiegel D, Meyer J, et al. Fibromatosis in childhood: the desmoid/fibromatosis complex. Med Pediatr Oncol. 2001;37:126-131.
7. Sorensen A, Keller J, Nielsen OS, et al. Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1-27 years. Acta Orthop Scand. 2002;73:213-219.
8. Ballo MT, Zagars GK, Pollack A, et al. Desmoid tumors: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999;17:158-167.
9. Ballo MT, Zagars GK, Pollack A, et al. Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys. 1998;42:1007-1014.
10. Mechant TE, Nguyen D, Walter AW, et al. Long-term results with radiation therapy for pediatric desmoid tumors. Int J Radiat Oncol Biol Phys. 2000;47:1267-1271.
11. Plukker JT, van Oort I, Vermey A, et al. Aggressive fibromatosis (non-familial desmoids tumors): therapeutic problems and role of adjuvant radiotherapy. Br J Surg. 1995;82:510-514.
12. Skapek SX, Hawk BJ, Hoffer FA, et al. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol. 1998;16:3021-3027.
13. Reich S, Overberg-Schmidt US, Buhrer C, Henze G. Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors [letter]. J Clin Oncol. 1999;17:1086. Comment on J Clin Oncol. 1998;16:3021-3027.
14. Lackner H, Urban C, Benesch M, et al. Multimodal treatment of children with unresectable desmoid tumors: an 11-year longitudinal observational study. J Pediatr Hematol Oncol. 2004;26:518-522.
15. Lackner H, Urban C, Kerbi R, et al. Noncytotoxic drug therapy in children with unresectable desmoid tumors. Cancer. 1997;80:334-340.
16. Raney B, Evans A, Granowetter L, et al. Nonsurgical management of children with recurrent or unresectable fibromatosis. Pediatrics. 1987;79:394-398.
17. Buitendijk S, Van de ven CP, Dumans TG, et al. Pediatric aggressive fibromatosis. Cancer. 2005;104:1090-1099.
18. Skapek SX, Ferguson WS, Granowetter L, et al. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group phase II trial. J Clin Oncol. 2007;25:501-506.
19. Azzarelli A, Gronchi A, Beretulli et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer. 2001;92:1259-1264.
20. Lev D, Kotilingam D, Wei C, et al. Optimizing treatment of desmoid tumors. J Clin Oncol. 2007;25:1785-1791.
21. Patel SR, Benjamin RS. Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol. 2006;24:11-12.
22. Heinrich MC, McArthur GA, Demetri GD, et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol. 2006;24:1195-1203.
23. Lewis JJ, Boland BJ, Dennis HYL, et al. The enigma of desmoid tumors. Ann Surg. 1999;229:866-873.
24. Shreyaskumar RP, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer. 1993;72:3244-3247.
25. Weiss AJ, Lackman RD. Low dose of chemotherapy of desmoid tumors. Cancer. 1989;67:1192-1194.
26. Spear MA, Jennings LC, Mankin HJ, et al. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys. 1998;40:637-645.
27. Merchant NB, Lewis JJ, Woodruff JM, et al. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer. 1999;86:2045-2052.
28. Phillips SR, A'Hern R, Thomas JM. Aggressive fibromatosis of the abdominal wall, limbs and limb girdles. Br J Surg. 2004;91:1624-1629.
29. Bonvalot S, Eldweny H, Haddad V, et al. Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol. 2008;34:462-468.
30. Guadagnolo BA, Zagars GK, Ballo MT, et al. Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2008;71:441-447.
31. Hosalkar HS, Torbert JT, Fox EJ, et al. Musculoskeletal desmoid tumors. J Am Acad Orthop Surg. 2008;16:188-198.
32. Lazar AJ, Tuvin D, Hajibashi S, et al. Specific mutations in the β-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol. 2008;173:1518-1527.